Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
120 participants
INTERVENTIONAL
2011-11-30
2014-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
standard of care
patients receive standard care
No interventions assigned to this group
Coffee orally
patients will receive standard of care plus coffee orally
coffee
patients will receive a cup of coffee at room temperature orally twice daily
coffee rectally
patients receive standard of care plus coffee rectally
coffee rectally
patients receive an enema of two cups of coffee at room temperature once daily
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
coffee
patients will receive a cup of coffee at room temperature orally twice daily
coffee rectally
patients receive an enema of two cups of coffee at room temperature once daily
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* requires ventilator support for an anticipated more than 72 hours
* age older than 18 years
Exclusion Criteria
* known allergy to coffee
* mechanical ileus
* presence of enterostoma
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital Heidelberg
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Christoph Eisenbach
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christoph Eisenbach
Role: PRINCIPAL_INVESTIGATOR
University of Heidelberg, Heidelberg, Germany
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University hospital of Heidelberg
Heidelberg, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
COFFEE
Identifier Type: -
Identifier Source: org_study_id